Condition: Asthma
Intervention: Drug: salbutamol sulfate + ipratropium bromide
Sponsor: Boehringer Ingelheim
Terminated – verified July 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Intervention: Drug: salbutamol sulfate + ipratropium bromide
Sponsor: Boehringer Ingelheim
Terminated – verified July 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: Respimat® Budesonide low dose; Drug: Respimat® Budesonide high dose; Drug: Turbohaler® Budesonide; Drug: Placebo
Sponsor: Boehringer Ingelheim
Completed – verified July 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Cigarette smoking increased risk for severity in new-onset adult asthma
Healio Patients with new-onset adult asthma and a history of smoking had an increased risk for asthma severity within 2 years of diagnosis, according to recent study results. Researchers in Amsterdam studied 200 adults with new-onset asthma. A comprehensive … |
View full post on asthma – Google News
Conditions: Asthma; Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Budesonide; Drug: Procaterol
Sponsor: Intech Biopharm Ltd.
Completed – verified June 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Intervention:
Sponsor: AstraZeneca
Not yet recruiting – verified May 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: Budesonide Inhalation Aerosol (PT008) Dose 1; Drug: Budesonide Inhalation Aerosol (PT008) Dose 2; Drug: Budesonide Inhalation Aerosol (PT008) Dose 3; Drug: Budesonide Inhalation Aerosol (PT008) Dose 4; Drug: Placebo
Sponsor: Pearl Therapeutics, Inc.
Not yet recruiting – verified April 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Intervention: Drug: Methacholine Chloride (SK-1211)
Sponsor: Sanwa Kagaku Kenkyusho Co., Ltd.
Recruiting – verified March 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Parent Herald |
Removing mold may reduce adult asthma risk
Reuters The more mold participants reported having seen in their homes, the greater their asthma symptoms, researchers found. Men were especially vulnerable with a four-fold increase in the odds of having non-allergic asthma after recent exposure to visible mold. Mold exposure raises risk of adult asthma |
View full post on asthma – Google News
Condition: Asthma
Interventions: Drug: Budesonide and formoterol fumarate dehydrate (BF) SPIROMAX; Drug: SYMBICORT TURBOHALER budesonide and formoterol fumarate
Sponsors: Teva Pharmaceutical Industries; Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting – verified February 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Study: Adult women more affected by asthma than men
News 10NBC However, a new study finds women in their 40's and 50's are hospitalized more than twice as often for asthma symptoms than men in that age group. Researchers say this may mean asthma has specific biological traits common in young boys and older … |
View full post on asthma – Google News